hs-TnT helps identify patients of HFpEF likely to benefit from sacubitril/valsartan: Study Dr. Shravani Dali29 July 2021 3:30 AM GMTThe baseline hs-TnT was linked with increased risk of cardiovascular death or Hospitalization due to heart failure and these patients tend to ...
BNP is "cardio-protective", STOP-HF study opens gates for next-gen therapeutics dr. Abhimanyu Uppal19 July 2021 4:30 AM GMTB-type natriuretic peptide (BNP) possesses blood-pressure-lowering, antifibrotic, and aldosterone-suppressing properties. A recent analysis of STOP-HF ...
Sotagliflozin use linked to reduced risk of heart attack, heart failure and stroke in diabetics: Study Medha15 July 2021 3:30 AM GMTSotagliflozin is not FDA approved and if it is brought to the market, it would signify a major advance in the care of patients with diabetes, especiall...
DMARD therapy in autoimmune diseases may increase Heart failure risk: JACC Dr Satabdi Saha15 July 2021 3:15 AM GMTIn a recent research report, researchers have found that there is an association between heart failure status and use of specific DMARD therapy in...
Mavacamten improves health status of patients of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Lancet Dr. Shravani Dali13 July 2021 3:30 AM GMTMavacamten significantly showed better health status as compared to the placebo in patients with symptomatic obstructive hypertrophic...
Beta-Blockers Reduce In-Hospital Mortality in Patients With Acute Decompensated HF: Study MD Bureau12 July 2021 3:30 AM GMTBeta blocker use at admission was associated with lower in hospital mortality in patients with acute decompensated heart failure.
EMPEROR-Preserved confirms success of Empagliflozin in HFpEF Hina Zahid8 July 2021 4:15 AM GMTEmpagliflozin therapy with specific benefits in patients with heart failure and preserved ejection fraction (HFpEF) may finally be on its way as the...
CAD linked to more than 90% patients of HF with preserved ejection fraction: JAMA dr. Abhimanyu Uppal30 Jun 2021 3:38 AM GMTCoronary artery disease (CAD) and coronary microvascular dysfunction (CMD) may contribute to the pathophysiologic characteristics of heart failure...
Heart failure patients more likely to develop cancer of all types, finds Study Hina Zahid28 Jun 2021 4:30 AM GMTSophia Antipolis: Heart failure affects around 65 million people worldwide. Some patients with cancer develop heart failure as a consequence of cancer ...
Statin use reduces mortality due to cancer in heart failure, finds Study Hina Zahid25 Jun 2021 4:15 AM GMTThe study highlights the relationship between heart failure and cancer development and provides important information regarding the possibility of redu...
Higher-dose IV iron confers greater cardiovascular benefit in patients on dialysis: Study Medha25 Jun 2021 3:30 AM GMTUK: The use of higher-dose IV iron in patients on hemodialysis significantly lowers the risk of heart failure hospitalization, finds a recent study in ...
FDA Approves SOAANZ for Edema due to heart Failure or Renal Disease in adults Hina Zahid24 Jun 2021 4:42 AM GMTThe Food and Drug Administration (FDA) has approved Soaanz (torsemide) for the treatment of edema associated with heart failure or renal disease in...
